Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine

References

• Akbulut S, Elbe H, Eris C, et al. (2014). Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats. World J Gastroenterol 29:10158–65
   Google Scholar
• Bao TD, Li YG, Weng XG, et al. (2011). Studies on pharmacokinetics of evodiamine and rutaecarpine in rats plasma after oral administration extracts of Euodiae Fructus. Chin J Chin Mater Med 36:3519–22
   Google Scholar
• Bironaite D, Ollinger K. (1997). The hepatotoxicity of rhein involves impairment of mitochondrial functions. Chem Biol Interact 103:35–50
   PubMed Web of Science ®Google Scholar
• Cai XY, Meng N, Yang B. (2006). Analysis of 1 cases of poisoning caused by overdose of Evodia rutaecarpa. Beijing J TCM 25:171–2
   Google Scholar
• Chen F, Li S, Li D, et al. (2012). Transdermal behaviors comparisons among Evodia rutaecarpa extracts with different purity of evodiamine and rutaecarpine and the effect of topical formulation in vivo. Fitoterapia 83:954–60
   PubMed Web of Science ®Google Scholar
• Dey P, Saha MR, Sen A. (2014). Hepatotoxicity and the present herbal hepatoprotective scenario. Int J Green Pharmacy 9:265–73
   Google Scholar
• Feng S, He X. (2013). Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity. Curr Drug Metab 14:1–25
   Google Scholar
• Grimm SW, Einolf HJ, Hall SD, et al. (2009). The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos 37:1355–70
   PubMed Web of Science ®Google Scholar
• He LN, Yang AH, Cui TY, et al. (2015). Reactive metabolite activation by CYP2C19-mediated rhein hepatotoxicity. Xenobiotica 45:361–72
   Google Scholar
• Iwata H, Tezuka Y, Kadota SS, et al. (2005). Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract. Drug Metab Pharmacokinet 20:34–45
   PubMedGoogle Scholar
• Jia S, Hu C. (2010). Pharmacological effects of rutaecarpine as a cardiovascular protective agent. Molecules 15:1873–81
   PubMed Web of Science ®Google Scholar
• Jose CP, Robert P, Li L, et al. (2002). A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. Rapid Commun Mass Spectrom 19:798–804
   Google Scholar
• Kassahun K, Pearson PG, Tang W, et al. (2001). Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem Res Toxicol 14:62–70
   PubMed Web of Science ®Google Scholar
• Lee SK, Kim NH, Lee J, et al. (2004a). Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s. Planta Med 70:753–7
   PubMed Web of Science ®Google Scholar
• Lee SK, Lee J, Lee ES, et al. (2004b). Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 18:1073–80
   PubMed Web of Science ®Google Scholar
• Lewis DF, Lake BG. (1996). Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues. Xenobiotica 26:723–53
   PubMed Web of Science ®Google Scholar
• Liu CX, Yi XL, Si DY, et al. (2011). Herb–drug interactions involving drug metabolizing enzymes and transporters. Curr Drug Metab 12:835–49
   PubMed Web of Science ®Google Scholar
• Ma YT, Feng S, Zhao JY, et al. (2013). A comparative syudy of enzyme kinetics of single-probe and mixed-probe on hepatic cytochrome 450. J Tianjin Univ Tradit Med 32:206–10
   Google Scholar
• Ma BL, Yao MK, Han XH, et al. (2011). Influences of Fructus evodiae pretreatment on the pharmacokinetics of Rhizoma coptidis alkaloids. Eur J Pharmacol 137:1395–401
   Google Scholar
• Grillo MP, Hua F, Knutson CG, et al. (2003). Mechanistic studies on the bioactivation of diclofenac: identification of diclofenac S-acyl-glutathione in vitro in incubations with rat and human hepatocytes. Chem Res Toxicol 16:1410–17
   PubMed Web of Science ®Google Scholar
• McClean S, Robinson RC, Shaw C, et al. (2002). Characterisation and determination of indole alkaloids in frog-skin secretions by electrospray ionisation ion trap mass spectrometry. Rapid Commun Mass Spectrom 16:346–54
   PubMed Web of Science ®Google Scholar
• Moon TC, Murakami M, Kudo I, et al. (1999). A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflam Res 48:621–5
   PubMed Web of Science ®Google Scholar
• Noh K, Seo YM, Lee SK, et al. (2011). Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats. Arch Pharm Res 34:119–25
   PubMed Web of Science ®Google Scholar
• Peterson LA, Cummings ME, Vu CC, et al. (2005). Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial. Drug Metab Dispos 33:1453–8
   PubMed Web of Science ®Google Scholar
• Reid M, Kuffel J, Miller K, et al. (1999). Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Clin Cancer Res 5:2192–7
   PubMed Web of Science ®Google Scholar
• Sasaki E, Matsuo K, Iida A, et al. (2013). A novel mouse model for phenytoin-induced liver injury: involvement of immune-related factors and P450-mediated metabolism. Toxicol Sci 135:250–63
   Google Scholar
• Sekiguchi N, Higashida A, Kato M, et al. (2009). Prediction of drug–drug interactions based on time-dependent inhibition from high through put screening of cytochrome P450 3A4 inhibition. Drug Metab Pharmacokinet 24:500–10
   PubMed Web of Science ®Google Scholar
• Slaughter RL, Edwards DJ. (1995). Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 29:619–24
   PubMed Web of Science ®Google Scholar
• Su P, Kaushal KM, Kroetz DL. (1998). Inhibition of renal arachidonic acid ω-hydroxylase activity with ABT reduces blood pressure in the SHR. Am J Physiol Regul 2:426–38
   Google Scholar
• Takaki H, Hirota F, Takashi S. (1983). Increase in the synthesis of a Mr 32,000 protein in BALB/c 3T3 cells treated with tumor-promoting indole alkaloids or polyacetates. Cancer Res 43:2415–21
   Google Scholar
• Tsai TH, Lee TF, Chen CF, et al. (1995). Thermoregulatory effects of alkaloids isolated from Wu-Chu-Yu in afebrile and febrile rats. Pharmacol Biochem Behav 50:293–8
   PubMed Web of Science ®Google Scholar
• Tsutomu S, Martha V, Martin D, et al. (1989). Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res 15:6304–12
   Google Scholar
• US Food and Drug Administration. (2012). Guidance for industry: drug interaction studies – study design, data analysis, implications for dosing, and labeling recommendations. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf [last accessed 4 Apr 2014]
   Google Scholar
• Wu WN, Linda A. (2002). The in vitro metabolism of thalicarpine, an aporphine benzyltetrahydroisoquinoline alkaloid, in the rat: API-MS/MS identification of thalicarpine and metabolites. J Pharm Biomed Anal 30:141–50
   PubMed Web of Science ®Google Scholar
• Xie C, Zhong DF, Chen XY. (2011). Applications of liquid chromatography–tandem mass spectrometry to detection and characterization of reactive metabolites. J Chin Mass Spectrom Soc 32:1–11
   Google Scholar
• Xu H, Chen KJ. (2010). Herb–drug interaction: an emerging issue of integrative medicine. Chin J Integr Med 3:195–6
   Google Scholar
• Zhou Q, Jin RM, Yao GT. (2013). Preliminary study on nephrocytes toxicity induced by four traditional Chinese medicine monomers in Evodia Rutaecarpa. Chin J Pharmacovigilance 10:1–4
   Google Scholar
• Zhuang XM, Shen GL, Xiao WB, et al. (2013). Assessment of the roles of P-glycoprotein and cytochrome P450 in triptolide-induced liver toxicity in sandwich-cultured rat hepatocyte model. Drug Metab Dispos 41:2158–65
   PubMed Web of Science ®Google Scholar